Randall M. St. Laurent
Corporate Officer/Principal chez mobilkom austria AG
Profil
Randall M.
St. Laurent is currently the Managing Director at mobilkom austria AG since 2009.
Previously, he held positions such as Sales Director at Genentech, Inc., Vice President-Commercial Development at Scios, Inc., Vice President-Sales at Portola Pharmaceuticals, Inc., Executive Vice President-Commercial Operations at ARCA biopharma, Inc., Vice President-Sales at Mallinckrodt Hospital Products, Inc., and Vice President-Sales at Theravance Biopharma US, Inc. He obtained his undergraduate degree from The Ohio State University.
Postes actifs de Randall M. St. Laurent
| Sociétés | Poste | Début |
|---|---|---|
mobilkom austria AG
 mobilkom austria AG Wireless TelecommunicationsCommunications mobilkom austria AG provides mobile communications services. Its services include voice telephony as well as mobile data communication, including UMTS, which also includes mobile payment solutions and the customer service segment. It operates a customer service center in Austria under the brand name Client24, which offers services in the areas of customer support, customer retention and customer acquisition. Founded in 1974, the company is headquartered in Vienna, Austria. | Corporate Officer/Principal | - |
Anciens postes connus de Randall M. St. Laurent
| Sociétés | Poste | Fin |
|---|---|---|
ARCA biopharma, Inc. /Old/
 ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | Corporate Officer/Principal | 28/01/2009 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Sales & Marketing | - |
Theravance Biopharma US, Inc.
 Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Sales & Marketing | - |
| PORTOLA PHARMACEUTICALS, INC. | Sales & Marketing | - |
| CADENCE PHARMACEUTICALS, INC. | Sales & Marketing | - |
Formation de Randall M. St. Laurent
| The Ohio State University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARCA BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | Health Technology |
mobilkom austria AG
mobilkom austria AG Wireless TelecommunicationsCommunications mobilkom austria AG provides mobile communications services. Its services include voice telephony as well as mobile data communication, including UMTS, which also includes mobile payment solutions and the customer service segment. It operates a customer service center in Austria under the brand name Client24, which offers services in the areas of customer support, customer retention and customer acquisition. Founded in 1974, the company is headquartered in Vienna, Austria. | Communications |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Commercial Services |
